KIMBERLY CRICCHI: Open Payments
NPI 1174397558 · GUILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 44 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $950 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 10 | $263 |
| Madrigal Pharmaceuticals | 7 | $169 |
| Janssen Biotech, Inc. | 4 | $155 |
| PFIZER INC. | 7 | $144 |
| ABBVIE INC. | 4 | $99 |
| Phathom Pharmaceuticals, Inc. | 3 | $65 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Gilead Sciences, Inc. | 2 | $33 |
| QOL Medical, LLC | 1 | $23 |
Products named: IBSRELA, REZDIFFRA, TREMFYA, XELJANZ, VOQUEZNA, DUPIXENT, SKYRIZI, VELSIPITY.
Industry payments across CT — which companies pay providers there.
